Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Hepatocellular | 6 | 2023 | 163 | 3.440 |
Why?
|
| Liver Neoplasms | 6 | 2023 | 224 | 3.290 |
Why?
|
| MicroRNAs | 7 | 2022 | 518 | 2.950 |
Why?
|
| Apoptosis Regulatory Proteins | 4 | 2021 | 161 | 2.350 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2022 | 968 | 1.730 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2019 | 307 | 1.570 |
Why?
|
| Autophagy | 5 | 2022 | 140 | 1.520 |
Why?
|
| Fluorocarbons | 2 | 2023 | 42 | 1.510 |
Why?
|
| Prostatic Neoplasms | 4 | 2022 | 1092 | 1.400 |
Why?
|
| Contact Tracing | 1 | 2026 | 25 | 0.960 |
Why?
|
| Yin-Yang | 1 | 2025 | 3 | 0.950 |
Why?
|
| Disclosure | 1 | 2026 | 39 | 0.940 |
Why?
|
| Neoplasms | 3 | 2021 | 1377 | 0.880 |
Why?
|
| Environment | 1 | 2025 | 149 | 0.860 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 1019 | 0.860 |
Why?
|
| Cell Proliferation | 8 | 2022 | 1455 | 0.860 |
Why?
|
| Environmental Exposure | 1 | 2025 | 256 | 0.790 |
Why?
|
| Bacterial Toxins | 1 | 2023 | 50 | 0.780 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 112 | 0.780 |
Why?
|
| Alkanesulfonic Acids | 1 | 2022 | 9 | 0.770 |
Why?
|
| Humans | 24 | 2026 | 43102 | 0.770 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2021 | 13 | 0.720 |
Why?
|
| Cell Line, Tumor | 7 | 2023 | 2676 | 0.710 |
Why?
|
| Vaccines | 1 | 2021 | 65 | 0.660 |
Why?
|
| Cell Movement | 5 | 2022 | 655 | 0.650 |
Why?
|
| Adipocytes | 1 | 2020 | 60 | 0.630 |
Why?
|
| Environmental Pollutants | 1 | 2022 | 201 | 0.630 |
Why?
|
| Signal Transduction | 5 | 2020 | 2157 | 0.620 |
Why?
|
| Fatty Liver | 1 | 2020 | 77 | 0.600 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 178 | 0.590 |
Why?
|
| North Carolina | 3 | 2026 | 127 | 0.580 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 83 | 0.580 |
Why?
|
| Oncogenes | 1 | 2018 | 44 | 0.580 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 88 | 0.580 |
Why?
|
| Exosomes | 1 | 2020 | 126 | 0.570 |
Why?
|
| Receptors, Notch | 1 | 2018 | 38 | 0.570 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 139 | 0.560 |
Why?
|
| Serotonin | 1 | 2018 | 123 | 0.550 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 165 | 0.540 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 228 | 0.530 |
Why?
|
| 3' Untranslated Regions | 3 | 2022 | 82 | 0.490 |
Why?
|
| Animals | 9 | 2025 | 16992 | 0.450 |
Why?
|
| Health Status Disparities | 1 | 2020 | 719 | 0.410 |
Why?
|
| Fibrosis | 2 | 2023 | 169 | 0.370 |
Why?
|
| Cell Survival | 3 | 2021 | 945 | 0.370 |
Why?
|
| Male | 8 | 2026 | 23409 | 0.350 |
Why?
|
| Rural Population | 2 | 2026 | 373 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 299 | 0.290 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2021 | 384 | 0.270 |
Why?
|
| Cues | 1 | 2025 | 81 | 0.220 |
Why?
|
| Adaptation, Physiological | 1 | 2025 | 143 | 0.220 |
Why?
|
| Trust | 1 | 2026 | 167 | 0.210 |
Why?
|
| Mice | 3 | 2020 | 6644 | 0.200 |
Why?
|
| Microcystins | 1 | 2023 | 8 | 0.200 |
Why?
|
| Young Adult | 2 | 2026 | 5080 | 0.190 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 291 | 0.190 |
Why?
|
| Cadmium | 1 | 2023 | 56 | 0.190 |
Why?
|
| Unfolded Protein Response | 1 | 2022 | 22 | 0.190 |
Why?
|
| Caprylates | 1 | 2022 | 14 | 0.190 |
Why?
|
| Adolescent | 2 | 2026 | 6081 | 0.190 |
Why?
|
| Zebrafish | 1 | 2023 | 146 | 0.180 |
Why?
|
| Sirolimus | 1 | 2022 | 70 | 0.180 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2021 | 32 | 0.170 |
Why?
|
| Leptin | 1 | 2022 | 118 | 0.170 |
Why?
|
| Apoptosis | 2 | 2019 | 1568 | 0.170 |
Why?
|
| Metabolism | 1 | 2020 | 9 | 0.170 |
Why?
|
| Prostate-Specific Antigen | 1 | 2022 | 147 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 60 | 0.160 |
Why?
|
| Glycolysis | 1 | 2020 | 71 | 0.160 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 638 | 0.160 |
Why?
|
| Infant | 1 | 2023 | 1175 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2024 | 502 | 0.150 |
Why?
|
| Base Sequence | 1 | 2021 | 983 | 0.150 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2018 | 2 | 0.150 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 38 | 0.150 |
Why?
|
| Transplantation, Heterologous | 1 | 2018 | 98 | 0.150 |
Why?
|
| Transfection | 1 | 2020 | 532 | 0.150 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 63 | 0.140 |
Why?
|
| Logistic Models | 1 | 2021 | 1009 | 0.140 |
Why?
|
| Middle Aged | 2 | 2026 | 12222 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2021 | 536 | 0.140 |
Why?
|
| RNA Interference | 1 | 2019 | 247 | 0.140 |
Why?
|
| Comorbidity | 1 | 2020 | 737 | 0.140 |
Why?
|
| Cell Cycle | 1 | 2019 | 346 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 200 | 0.130 |
Why?
|
| Community-Based Participatory Research | 1 | 2021 | 352 | 0.130 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 237 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 159 | 0.130 |
Why?
|
| Adult | 2 | 2026 | 13872 | 0.130 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 193 | 0.130 |
Why?
|
| Prognosis | 1 | 2019 | 861 | 0.130 |
Why?
|
| Obesity | 1 | 2022 | 1151 | 0.100 |
Why?
|
| Female | 2 | 2026 | 24698 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 1869 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3156 | 0.100 |
Why?
|
| Aged | 1 | 2026 | 8214 | 0.100 |
Why?
|
| Risk Factors | 1 | 2020 | 3994 | 0.090 |
Why?
|
| United States | 1 | 2020 | 5205 | 0.080 |
Why?
|